PTSDPhase 2NCT03534583
SKY vs. HEP in PTSD
A Phase 2 study testing Sudarshan Kriya Yoga and Health Enhancement Program in people with PTSD, run by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's at 1 site in Canada.
Trial summary
Post-traumatic stress disorder (PTSD) is the third most common mental illness with a lifetime prevalence rate of 9.2% in Canada. Depression and anxiety are common comorbidities making treatment complex. Currently available treatments for PTSD include medications and talk therapies. Read more about this study
- Who is it for?
- Ages 18 to 75 years
- Conditions the study is for
- PTSD
- What is being tested?
- Sudarshan Kriya Yoga and Health Enhancement Program
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 49 participants
- Where
- 1 siteCanada
- Study dates
- 1 Aug 2018to 29 May 2022
- Phase
- Phase 2
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 75 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Between the age of 18 and 75.
- Has confirmed Axis 1 diagnosis of PTSD as per CAPS5
- Sufficiently able to hear allowing them to follow verbal instructions. Able to communicate sufficiently in English.
- Able to sit without physical discomfort for 60 minutes.
- Willing and able to attend 6 initial SKY training sessions and 75% of follow up sessions.
- Not pregnant and willing to remain not pregnant for the Duration of the study.
- Access to a device with a camera and microphone, internet access, and a private space large enough to accommodate a yoga mat (a yoga mat is not required a comfortable floor space or blanket can be substituted).
Who cannot join
- Currently participating in other studies on PTSD treatment.
- Score severe or extreme on Depersonalization (item 29) or Derealization (item 30) of CAPS5.
- Have other significant mental health diagnosis including bipolar disorder, Schizophrenia, Neurocognitive disorder, and/or severe Personality Disorder (confirmed by Psychiatrist and MINI).
- Have significant substance dependence, or for those that have significant substance use disorder (have been regularly using within 6 weeks prior to commencement of intervention) or are unable to attend the intervention and assessment sessions while not under the influence of a substance.
- Have a risk of suicide as elicited by clinical interview (MINI).
- Have psychotic episodes within the past 12 months.
Show all 13Show fewer
- Have a Traumatic Brain Injury (TBI) as defined by loss of consciousness for more than 20 minutes and/or Glasgow Coma Scale score less than or equal to 12.
- Non-professionals with complex PTSD. Professionals include those who have served in the Canadian armed forces, are public safety personnel or are health care professionals.
- Currently practice any type of formal meditation, mindfulness or breathing techniques regularly.
- Have serious cardiovascular disease in the past 12 months (i.e.myocardial infarction, stroke, uncontrolled hypertension or TIA), or a past history of neurological disease (including Parkinson's Disease), seizures, or diabetic neuropathy.
- Major surgery within 8 weeks prior to commencement of the intervention, or a scheduled major surgery during the intervention period.
- Have mental health difficulties that has prevented participant from leaving the house, and/or missed appointments in last 3 months.
- Have vacation plans that will interfere with participant's ability to participate in the study.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Alternative Treatments to Help Post Traumatic Stress Disorder
Post-traumatic stress disorder (PTSD) is the third most common mental illness with a lifetime prevalence rate of 9.2% in Canada. Depression and anxiety are common comorbidities making treatment complex. Currently available treatments for PTSD include medications and talk therapies. However, their best combined response rates are around 50%. Our recent pilot feasibility study showed potential benefits of a breathing based meditation intervention called Sudarshan Kriya Yoga (SKY) in PTSD, as an augmentation treatment. The investigators seek to now assess the safety and efficacy of SKY intervention compared to an active control, Health Enhancement Program (HEP) in a double blind randomized controlled trial. The investigators will include PTSD patients with a wide range of trauma experience including road traffic accidents, childhood, physical, emotional or sexual abuse, or recurrent traumas over the lifespan. Patients will be offered a 12-week program of either SKY or HEP interventions as an add-on to their existing treatment schedules. This study will examine if patients with PTSD experience a reduction in PTSD symptoms from baseline to 12-week follow-up, as measured by the PCL-5 after receiving either HEP or SKY.
Read the detailed description
STUDY DESIGN: Single-center, blinded (rater, investigator, and clinician), longitudinal, RCT comparing a 12-week SKY online intervention group to a 12-week HEP online intervention group.
STUDY RECRUITMENT: Participants include men and women (n=130), 18-75 years of age, with PTSD. The study will recruit via referrals from the General Adult Ambulatory, the Traumatic Stress Services Program (TSS), the PTSD clinical research unit and the Geriatric Mental Health Program of London Health Sciences Centre at an expected rate of approximately 1 to 2 participants per week. Referred participants will be individuals who in the opinion of investigators or referring physicians will likely meet inclusion and exclusion criteria. A letter will be sent to primary care physicians in London, ON and surrounding area requesting the referral of potential participants. The letter will be accompanied by a poster advertising the study and by a list of the studies inclusion/exclusion criteria. Posters will also be placed online on the websites of the studies investigators as well as websites and social media sites of relevant organizations such as Project Trauma Support and Ivegotyourback911. Online posters will indicate that individuals should not share or comment on posters to protect their identity. Printed posters will be placed in community centres, libraries, hospitals, medical centres, locations where veterans frequent, and locations where first responders work such as fire halls and police stations. Information sessions will be held at locations where first responders work or may frequent to inform potential participants about the study.
SCREENING AND INITIAL ASSESSMENT: Referred potential participants will be provided with a Letter of Information (LOI) to review and consider. Participants will be given a minimum of 24 hours to review the LOI before being contacted over-the-phone by one of the study Research Assistants (RA). During this initial phone call the RA will answer any questions the potential participants have, briefly explain the study, and invite potential participants to a screening appointment to be conducted either remotely or in person. During the initial screening appointment participants will complete the informed consent process which includes an opportunity to ask any questions. Participants will be screened for inclusion and exclusion criteria by a trained member of the research team. These participants will have clinically diagnosed PTSD, further confirmed through a structured clinical interview, the Clinician-administered PTSD Scale for DSM5-past month version (CAPS5). Any additional diagnoses will be screened by the MINI (Mini International Neuropsychiatric Interview). The CAPS5 will also be used to rule out severe depersonalization and derealization as per exclusion criteria. If the participant is above the age of 65 years of age, they will complete a cognitive screening test using the Mini Mental State Examination, MMSE>24 to rule out significant cognitive impairment. Participants meeting all study criteria who wish to join the study will be enrolled and assigned a unique study identifier e.g. HEPSKY001.
RANDOMIZATION: Participants meeting inclusion criteria will be randomized to either SKY or HEP with equal probability (1:1), stratified by gender, using computer generated randomisation numbers. Concealment of randomisation to outcome assessors and investigators will be ensured by an independent consultant who will perform the randomization. The independent consultant will be responsible for randomization and will inform an unblinded study team member of allocation codes. The unblinded study team member will send an email to study participants informing them of their treatment allocation.
TRIAL INTERVENTIONS: The investigators will offer the two interventions, online via Cisco WebEx, in groups of 6-8 participants on a rolling basis 1. Sudarshan Kriya Yoga (SKY): 1. Participants in the SKY group will undergo a 12-week training course conducted by certified teachers of the Art of Living Foundation. 2. HEP Intervention: Participants in HEP will learn about health promotion, healthy diet, music, and exercise, but will not learn breathing techniques, or meditation. HEP will be delivered by trained staff.
All participants will continue to receive standard care through their providers.
STATISTICAL ANALYSIS PLAN: All statistical analyses will be run with the level of statistical significance set at 0.05. Independent samples t tests (for continuous variables) or chi-squared analyses (for categorical variables) will be used to identify whether any differences in demographic or clinical characteristics exist between patients assigned to SKY and HEP. Any variables showing statistically significant differences will be controlled for in the analyses, and sub-group analyses will be completed, as appropriate, to estimate the effect of various demographic or clinical variables. For our Primary Objective 1, the change in PCL-5 scores from baseline to 12-week follow-up of patients assigned to SKY and HEP will be compared using linear mixed models. This approach will account for the clustering of observations since both SKY and HEP will be delivered in a group setting. We will evaluate whether a greater proportion of patients assigned to SKY, compared to HEP, respond to treatment (decrease of at least 10 points on the PCL-5), or go into remission (defined as a PCL-5 score <33), using generalized linear mixed models. In evaluating our Secondary Objectives; depressive symptoms, anxiety, and quality of life, the change score for each measure from baseline to 12-week follow-up of patients assigned to SKY and HEP will be compared using linear mixed models. In evaluating our Exploratory Objectives, linear mixed models will also be used to evaluate the change in levels of inflammatory markers and HF-HRV from baseline to the 12-week follow-up. Correlation analyses will be used to evaluate whether improvement in PCL-5 scores is associated with greater improvement in levels of inflammatory markers and HR-HRV. Lastly, we will evaluate whether the effects found at the 12-week follow-up are maintained at six months. The above analyses (linear mixed models and generalized linear mixed models) will be repeated for PTSD symptoms, depressive symptoms, anxiety and quality of life, comparing scores at baseline and six-months.
Interim analysis may be completed in order to meet one or more of these conditions a) sponsor reporting requirements and/or b) research training requirements of residents and/or c) data safety monitoring board meetings for stop or continue decisions. Prior research ethics board approval will be sought before any interim analysis is conducted.
- Conditions
- PTSD
- Being tested
- Sudarshan Kriya Yoga, Health Enhancement Program
- Medical subject headings
- Stress Disorders, Post-Traumatic
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Sudarshan Kriya YogaOther
Also called SKY
Participants in the SKY group will undergo an oline 12-week training course conducted by certified teachers of the Art of Living Foundation
Health Enhancement ProgramOther
Also called HEP
Participants in the online HEP will learn about health promotion, healthy diet, music, and exercise, but will not learn breathing techniques, or meditation. HEP will be delivered by trained staff.
| Study group | Role | What they receive |
|---|---|---|
| Health Enhancement Program (HEP) | Active comparator | The Health-Enhancement Program (HEP) is structurally equivalent to a SKY intervention, with similar-sized groups, meeting for 3 consecutive days for 1.5-3 hours. There will then be a a gap of 4 days where participants will practice what they have learned, followed by 3 consecutive days of 1.5-3 hours of instruction. Starting the following week participants will attend once weekly follow up sessions (60-90 min/wk) for 3 weeks and then bimonthly sessions for the next 8 weeks. Participants will be asked to complete 25 min/day of course homework. Participants will learn about health promotion, healthy diet, music, and exercise, but do not learn breathing techniques, or meditation. In HEP, which has been manualized, participants get the support of a group and facilitator, and talk through and try to implement positive health-enhancing life changes, HEP will be delivered by a trained social worker (or equivalent). Receives: Other: Health Enhancement Program |
| Sudarshan Kriya Yoga (SKY) | Experimental | The SKY PTSD program is a mind-body resilience building program developed for persons with PTSD. Through SKY breathing, interactive discussions, journaling, yoga and guided meditations, the workshop builds a framework for resilience and empowerment, and develops self-awareness, connectedness and community, and a positive outlook. SKY training will take place in group-format (6-8 participants). During the first week participants will attend three 2.5-3 hour sessions on three consecutive days. There will then be a gap of 4 days where participants can apply the tools provided, followed by three more consecutive days of 1.5-3 hours of instruction. This will be followed by once weekly follow up sessions (90 min/wk) for 3 weeks and then bimonthly sessions (every 2 weeks) for the next 8 weeks. In addition, participants will be asked to practice SKY at home daily (25 min/day) throughout the duration of the study period (up to 26 weeks) and log practice frequency. Receives: Other: Sudarshan Kriya Yoga |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Post traumatic stress disorder check list (PCL-5)
The PCL-5 is a 20-item self-report measure that assesses the presence and severity of PTSD symptoms. Participants will be asked to rate how bothered they have been by each item in the past month on a 5-point Likert scale ranging from 0-4. Items are summed to provide a total score ranging from 0 to 80, with higher scores indicating more severe symptoms of PTSD.
Measured: Change from baseline to weeks 4, 8, 12 and 26.
Secondary outcomes (14)
Change in Hamilton Depression Scale (HAMD-17)
The HAMD-17 is a 17 item rater administered questionnaire that assesses the severity of the participants depression over the previous two weeks. Scores range from 0 to 50. Higher scores indicated more severe depression.
Measured: Change from baseline to weeks 4, 8, 12 and 26.
Change in Beck's Depression Inventory (BDI)
The BDI is a self rated measure of participants depression. The scale consists of 21 questions each with scores ranging from 0 to 3. Total scores range from 0 to 63, with higher scores indicating more severe depression.
Measured: Change from baseline to weeks 4, 8, 12 and 26
Change in Hamilton Anxiety Scale (HAM-A)
The rater administered HAM-A measures anxiety. The 14 item questionnaire results in a score range of 0 to 56 with higher scores indicating greater anxiety.
Measured: Change from baseline to weeks 4, 8, 12 and 26.
Change in Toronto Side Effects Scale (TSES)
The 32 item TSES measures side effects by asking participants to rate both the frequency and severity of each item. An intensity score for each item is calculated by multiplying the frequency by the severity. Higher scores indicate more severe side effects.
Measured: Change from baseline to weeks 4, 8, 12 and 26
Change in World Health Organization Quality of Life Scale (WHOQOL-Bref)
The WHOQOL-Bref is a self-rated 26-item questionnaire that assess a participants quality of life. Scores are calculated for questions 1 and 2 and the four domains; physical health, psychological, social relationships and environment. A transformed score rates each of the 4 domains from 0 to 100 with higher scores indicating an improved quality of life.
Measured: Change from baseline ato weeks 4, 8, 12 and 26
Change in heart rate
Heart rate will be measured using an electrocardiogram (ECG).
Measured: Change from baseline to week 12 and week 26.
Change in Mean Diastolic Blood Pressure as measured by plethysmograph.
Blood pressures will be obtained manually using a standard plethysmograph by a trained research staff. Three manual blood pressures will be recorded at each time point (0, 12, and 26 weeks), from which the change in mean diastolic blood pressure will be computed.
Measured: Change from baseline to week 12 and week 26.
Change in Mean Systolic Blood Pressure as measured by plethysmograph.
Blood pressures will be obtained manually using a standard plethysmograph by a trained research staff. Three manual blood pressures will be recorded at each time point (0, 12, and 26 weeks), from which the change in mean systolic blood pressure will be computed.
Measured: Change from baseline to week 12 and week 26.
Change in blood levels of C- Reactive Protein (CRP).
Enzyme-linked immunosorbent assay (ELISA) will be used to assess blood levels of C- Reactive Protein (CRP).
Measured: Change from baseline to week 12 and week 26.
Change in Heart Rate Variability (HRV).
Heart rate variability (HRV) will be measured using an electrocardiogram (ECG). HRV, will be calculated by standard deviation of all R-R intervals (SDNN) on ECG, root-mean square of successive differences (RMSSD), and number of R-R intervals differing by >50 m sec from adjacent intervals (NN50) in time domain analysis.
Measured: Change from baseline to week 12 and week 24.
Change in blood levels of Interleukin-6 (IL-6)
ELISA will be used to assess blood levels Interleukin-6 (IL-6)
Measured: change from baseline to week 12 and 24.
Change in blood levels of malondialdehyde (MDA)
ELISA will be used to assess blood levels of malondialdehyde (MDA).
Measured: Change from baseline to week 12 and week 24.
Change in blood levels of total antioxidant capacity
ELISA will be used to assess blood levels of total antioxidant capacity (including glutathione)
Measured: Change from baseline to week 12 and week 24.
Change in blood levels of glutathione
ELISA will be used to assess blood levels of glutathione.
Measured: Change from baseline to week 12 and week 24.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 May 2018
- Study start1 Aug 2018
- Primary completion29 May 2022
- Study completion29 May 2022
Why it stopped: Terminated due to Covid-19 pandemic related restrictions
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for PTSDStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 2
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind
- Who is masked
- Care provider, Investigator, Outcomes assessor
- Enrolment
- 49 participants (actual)
Sponsor and investigators
- Lead sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Kamini Vasudev, London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03534583
- Sponsor's protocol ID
- 111756
- Status last verified
- May 2022
- First submitted
- 29 Apr 2018
- Last updated
- 1 Jun 2022
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 1 Jun 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Alternative Treatments to Help Post Traumatic Stress Disorder
- ClinicalTrials.gov ID
- NCT03534583
- Acronym / sponsor ID
- 111756
- Conditions
- PTSD
- Phase
- Phase 2
- Study type
- Interventional
- Recruitment status
- TerminatedReason stopped: Terminated due to Covid-19 pandemic related restrictions
- Enrolment
- 49 participants (actual)
- Lead sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sUniversity, hospital or other
- Study start
- 1 Aug 2018 (actual)
- Primary completion
- 29 May 2022 (actual)
- Study completion
- 29 May 2022 (actual)
- First posted
- 23 May 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Post-traumatic stress disorder (PTSD) is the third most common mental illness with a lifetime prevalence rate of 9.2% in Canada. Depression and anxiety are common comorbidities making treatment complex. Currently available treatments for PTSD include medications and talk therapies. However, their best combined response rates are around 50%. Our recent pilot feasibility study showed potential benefits of a breathing based meditation intervention called Sudarshan Kriya Yoga (SKY) in PTSD, as an augmentation treatment. The investigators seek to now assess the safety and efficacy of SKY intervention compared to an active control, Health Enhancement Program (HEP) in a double blind randomized controlled trial. The investigators will include PTSD patients with a wide range of trauma experience including road traffic accidents, childhood, physical, emotional or sexual abuse, or recurrent traumas over the lifespan. Patients will be offered a 12-week program of either SKY or HEP interventions as an add-on to their existing treatment schedules. This study will examine if patients with PTSD experience a reduction in PTSD symptoms from baseline to 12-week follow-up, as measured by the PCL-5 after receiving either HEP or SKY.
Detailed description
STUDY DESIGN: Single-center, blinded (rater, investigator, and clinician), longitudinal, RCT comparing a 12-week SKY online intervention group to a 12-week HEP online intervention group.
STUDY RECRUITMENT: Participants include men and women (n=130), 18-75 years of age, with PTSD. The study will recruit via referrals from the General Adult Ambulatory, the Traumatic Stress Services Program (TSS), the PTSD clinical research unit and the Geriatric Mental Health Program of London Health Sciences Centre at an expected rate of approximately 1 to 2 participants per week. Referred participants will be individuals who in the opinion of investigators or referring physicians will likely meet inclusion and exclusion criteria. A letter will be sent to primary care physicians in London, ON and surrounding area requesting the referral of potential participants. The letter will be accompanied by a poster advertising the study and by a list of the studies inclusion/exclusion criteria. Posters will also be placed online on the websites of the studies investigators as well as websites and social media sites of relevant organizations such as Project Trauma Support and Ivegotyourback911. Online posters will indicate that individuals should not share or comment on posters to protect their identity. Printed posters will be placed in community centres, libraries, hospitals, medical centres, locations where veterans frequent, and locations where first responders work such as fire halls and police stations. Information sessions will be held at locations where first responders work or may frequent to inform potential participants about the study.
SCREENING AND INITIAL ASSESSMENT: Referred potential participants will be provided with a Letter of Information (LOI) to review and consider. Participants will be given a minimum of 24 hours to review the LOI before being contacted over-the-phone by one of the study Research Assistants (RA). During this initial phone call the RA will answer any questions the potential participants have, briefly explain the study, and invite potential participants to a screening appointment to be conducted either remotely or in person. During the initial screening appointment participants will complete the informed consent process which includes an opportunity to ask any questions. Participants will be screened for inclusion and exclusion criteria by a trained member of the research team. These participants will have clinically diagnosed PTSD, further confirmed through a structured clinical interview, the Clinician-administered PTSD Scale for DSM5-past month version (CAPS5). Any additional diagnoses will be screened by the MINI (Mini International Neuropsychiatric Interview). The CAPS5 will also be used to rule out severe depersonalization and derealization as per exclusion criteria. If the participant is above the age of 65 years of age, they will complete a cognitive screening test using the Mini Mental State Examination, MMSE>24 to rule out significant cognitive impairment. Participants meeting all study criteria who wish to join the study will be enrolled and assigned a unique study identifier e.g. HEPSKY001.
RANDOMIZATION: Participants meeting inclusion criteria will be randomized to either SKY or HEP with equal probability (1:1), stratified by gender, using computer generated randomisation numbers. Concealment of randomisation to outcome assessors and investigators will be ensured by an independent consultant who will perform the randomization. The independent consultant will be responsible for randomization and will inform an unblinded study team member of allocation codes. The unblinded study team member will send an email to study participants informing them of their treatment allocation.
TRIAL INTERVENTIONS: The investigators will offer the two interventions, online via Cisco WebEx, in groups of 6-8 participants on a rolling basis 1. Sudarshan Kriya Yoga (SKY): 1. Participants in the SKY group will undergo a 12-week training course conducted by certified teachers of the Art of Living Foundation. 2. HEP Intervention: Participants in HEP will learn about health promotion, healthy diet, music, and exercise, but will not learn breathing techniques, or meditation. HEP will be delivered by trained staff.
All participants will continue to receive standard care through their providers.
STATISTICAL ANALYSIS PLAN: All statistical analyses will be run with the level of statistical significance set at 0.05. Independent samples t tests (for continuous variables) or chi-squared analyses (for categorical variables) will be used to identify whether any differences in demographic or clinical characteristics exist between patients assigned to SKY and HEP. Any variables showing statistically significant differences will be controlled for in the analyses, and sub-group analyses will be completed, as appropriate, to estimate the effect of various demographic or clinical variables. For our Primary Objective 1, the change in PCL-5 scores from baseline to 12-week follow-up of patients assigned to SKY and HEP will be compared using linear mixed models. This approach will account for the clustering of observations since both SKY and HEP will be delivered in a group setting. We will evaluate whether a greater proportion of patients assigned to SKY, compared to HEP, respond to treatment (decrease of at least 10 points on the PCL-5), or go into remission (defined as a PCL-5 score <33), using generalized linear mixed models. In evaluating our Secondary Objectives; depressive symptoms, anxiety, and quality of life, the change score for each measure from baseline to 12-week follow-up of patients assigned to SKY and HEP will be compared using linear mixed models. In evaluating our Exploratory Objectives, linear mixed models will also be used to evaluate the change in levels of inflammatory markers and HF-HRV from baseline to the 12-week follow-up. Correlation analyses will be used to evaluate whether improvement in PCL-5 scores is associated with greater improvement in levels of inflammatory markers and HR-HRV. Lastly, we will evaluate whether the effects found at the 12-week follow-up are maintained at six months. The above analyses (linear mixed models and generalized linear mixed models) will be repeated for PTSD symptoms, depressive symptoms, anxiety and quality of life, comparing scores at baseline and six-months.
Interim analysis may be completed in order to meet one or more of these conditions a) sponsor reporting requirements and/or b) research training requirements of residents and/or c) data safety monitoring board meetings for stop or continue decisions. Prior research ethics board approval will be sought before any interim analysis is conducted.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind (care provider, investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Health Enhancement Program (HEP) | Active comparator | Other: Health Enhancement ProgramThe Health-Enhancement Program (HEP) is structurally equivalent to a SKY intervention, with similar-sized groups, meeting for 3 consecutive days for 1.5-3 hours. There will then be a a gap of 4 days where participants will practice what they have learned, followed by 3 consecutive days of 1.5-3 hours of instruction. Starting the following week participants will attend once weekly follow up sessions (60-90 min/wk) for 3 weeks and then bimonthly sessions for the next 8 weeks. Participants will be asked to complete 25 min/day of course homework. Participants will learn about health promotion, healthy diet, music, and exercise, but do not learn breathing techniques, or meditation. In HEP, which has been manualized, participants get the support of a group and facilitator, and talk through and try to implement positive health-enhancing life changes, HEP will be delivered by a trained social worker (or equivalent). |
| Sudarshan Kriya Yoga (SKY) | Experimental | Other: Sudarshan Kriya YogaThe SKY PTSD program is a mind-body resilience building program developed for persons with PTSD. Through SKY breathing, interactive discussions, journaling, yoga and guided meditations, the workshop builds a framework for resilience and empowerment, and develops self-awareness, connectedness and community, and a positive outlook. SKY training will take place in group-format (6-8 participants). During the first week participants will attend three 2.5-3 hour sessions on three consecutive days. There will then be a gap of 4 days where participants can apply the tools provided, followed by three more consecutive days of 1.5-3 hours of instruction. This will be followed by once weekly follow up sessions (90 min/wk) for 3 weeks and then bimonthly sessions (every 2 weeks) for the next 8 weeks. In addition, participants will be asked to practice SKY at home daily (25 min/day) throughout the duration of the study period (up to 26 weeks) and log practice frequency. |
Who may qualify
- Ages
- 18 to 75 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- Between the age of 18 and 75.
- Has confirmed Axis 1 diagnosis of PTSD as per CAPS5
- Sufficiently able to hear allowing them to follow verbal instructions. Able to communicate sufficiently in English.
- Able to sit without physical discomfort for 60 minutes.
- Willing and able to attend 6 initial SKY training sessions and 75% of follow up sessions.
Key exclusion criteria (13 listed)
- Currently participating in other studies on PTSD treatment.
- Score severe or extreme on Depersonalization (item 29) or Derealization (item 30) of CAPS5.
- Have other significant mental health diagnosis including bipolar disorder, Schizophrenia, Neurocognitive disorder, and/or severe Personality Disorder (confirmed by Psychiatrist and MINI).
- Have significant substance dependence, or for those that have significant substance use disorder (have been regularly using within 6 weeks prior to commencement of intervention) or are unable to attend the intervention and assessment sessions while not under the influence of a substance.
- Have a risk of suicide as elicited by clinical interview (MINI).
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Sudarshan Kriya YogaAlso: SKYParticipants in the SKY group will undergo an oline 12-week training course conducted by certified teachers of the Art of Living Foundation | Other | Sudarshan Kriya Yoga (SKY) |
| Health Enhancement ProgramAlso: HEPParticipants in the online HEP will learn about health promotion, healthy diet, music, and exercise, but will not learn breathing techniques, or meditation. HEP will be delivered by trained staff. | Other | Health Enhancement Program (HEP) |
Primary outcome
Change in Post traumatic stress disorder check list (PCL-5)
Time frame: Change from baseline to weeks 4, 8, 12 and 26.
The PCL-5 is a 20-item self-report measure that assesses the presence and severity of PTSD symptoms. Participants will be asked to rate how bothered they have been by each item in the past month on a 5-point Likert scale ranging from 0-4. Items are summed to provide a total score ranging from 0 to 80, with higher scores indicating more severe symptoms of PTSD.
14 secondary outcomes
Change in Hamilton Depression Scale (HAMD-17)
Time frame: Change from baseline to weeks 4, 8, 12 and 26.
Change in Beck's Depression Inventory (BDI)
Time frame: Change from baseline to weeks 4, 8, 12 and 26
Change in Hamilton Anxiety Scale (HAM-A)
Time frame: Change from baseline to weeks 4, 8, 12 and 26.
Change in Toronto Side Effects Scale (TSES)
Time frame: Change from baseline to weeks 4, 8, 12 and 26
Change in World Health Organization Quality of Life Scale (WHOQOL-Bref)
Time frame: Change from baseline ato weeks 4, 8, 12 and 26
Change in heart rate
Time frame: Change from baseline to week 12 and week 26.
Change in Mean Diastolic Blood Pressure as measured by plethysmograph.
Time frame: Change from baseline to week 12 and week 26.
Change in Mean Systolic Blood Pressure as measured by plethysmograph.
Time frame: Change from baseline to week 12 and week 26.
Change in blood levels of C- Reactive Protein (CRP).
Time frame: Change from baseline to week 12 and week 26.
Change in Heart Rate Variability (HRV).
Time frame: Change from baseline to week 12 and week 24.
Change in blood levels of Interleukin-6 (IL-6)
Time frame: change from baseline to week 12 and 24.
Change in blood levels of malondialdehyde (MDA)
Time frame: Change from baseline to week 12 and week 24.
Change in blood levels of total antioxidant capacity
Time frame: Change from baseline to week 12 and week 24.
Change in blood levels of glutathione
Time frame: Change from baseline to week 12 and week 24.
Results and safety
The study was stopped early (reason given: Terminated due to Covid-19 pandemic related restrictions). Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Jun 2022.
- Individual participant dataSharing planned: No
Related trials for PTSD
Not yet recruiting
FUS Neuromodulation for PTSD
Post Traumatic Stress Disorder PTSD
Recruiting
Evaluating Evidenced Based Options for PTSD Treatment
PTSD - Post Traumatic Stress Disorder
Not yet recruiting
BEAR for Women Who Have Experienced Sexual Assault and Have Suicidal Thoughts
Sexual Assault and Rape, Suicidal Thoughts
Recruiting
PTSD Screening in Pregnant Black Women
Pregnancy Early, PTSD
Not yet recruiting
Salience Network Informed rTMS for PTSD
Stress Disorders, Post-Traumatic
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 2 study testing Sudarshan Kriya Yoga and Health Enhancement Program in people with PTSD, run by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: stopped early, as of the sponsor's last update on 1 Jun 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
The study was stopped early (reason given: Terminated due to Covid-19 pandemic related restrictions). Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Post traumatic stress disorder check list (PCL-5) (time frame: Change from baseline to weeks 4, 8, 12 and 26.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jun 2022.